← ANALYST RATINGS · TIPRANKS
ClearPoint Neuro (CLPT): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months · top analysts only12-month forecast
Based on 1 price targets given in the last 3 months, the average target is —, the highest —, the lowest —. The average is — from the last price of $9.07.
Analyst ratings 3
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $10.00 → $9.00−10.0% | Hold | −0.8% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $10.00 → $9.00−10.0% | Hold | −0.8% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $10.00 → $9.00−10.0% | Hold | −0.8% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $9.50 → $8.50−10.5% | Sell | −6.3% | Downgrade | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $10.00 → $9.00−10.0% | Hold | −0.8% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $10.00 → $9.00−10.0% | Hold | −0.8% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $10.50 → $10.00−4.8% | Hold | +10.3% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $10.50 → $10.00−4.8% | Hold | +10.3% | Reiterated | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $10.00 → $9.50−5.0% | Sell | +4.7% | Downgrade | 14.10.26on TipRanks Oct 13 23:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $10.50 → $10.00−4.8% | Hold | +10.3% | Reiterated | 10.10.26on TipRanks Oct 9 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $11.00 → $10.50−4.5% | Hold | +15.8% | Reiterated | 10.10.26on TipRanks Oct 9 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $10.50 → $10.00−4.8% | Hold | +10.3% | Reiterated | 10.10.26on TipRanks Oct 9 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $10.50 → $10.00−4.8% | Hold | +10.3% | Reiterated | 10.10.26on TipRanks Oct 9 23:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $11.50 → $10.50−8.7% | Hold | +15.8% | Reiterated | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $11.50 → $11.00−4.3% | Hold | +21.3% | Reiterated | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $11.50 → $10.50−8.7% | Hold | +15.8% | Reiterated | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $11.00 → $10.00−9.1% | Sell | +10.3% | Downgrade | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $11.50 → $10.50−8.7% | Hold | +15.8% | Reiterated | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $11.50 → $10.50−8.7% | Hold | +15.8% | Reiterated | 04.10.26on TipRanks Oct 3 23:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $14.00 → $11.50−17.9% | Hold | +26.8% | Reiterated | 30.09.26on TipRanks 18:10 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $14.00 → $11.50−17.9% | Hold | +26.8% | Reiterated | 30.09.26on TipRanks 18:10 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $14.00 → $11.50−17.9% | Hold | +26.8% | Reiterated | 30.09.26on TipRanks 18:10 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $14.00 → $11.00−21.4% | Sell | +21.3% | Downgrade | 30.09.26on TipRanks 18:10 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $14.50 → $11.50−20.7% | Hold | +26.8% | Reiterated | 30.09.26on TipRanks 18:10 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $14.00 → $11.50−17.9% | Hold | +26.8% | Reiterated | 30.09.26on TipRanks 18:10 | — | |
| Frank Takkinen★★★★★★★★★★#11823 · hits 38% · avg −3.6% | Lake Street | $25.00 | Buy | +175.6% | Reiterated | 30.09.26on TipRanks Sep 29 09:31 | −22.9%next day +3.9% · 5 days −8.4% | ↗ |
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | — | Buy | — | Reiterated | 15.09.26on TipRanks 07:45 | −1.8%next day +2.3% · 5 days +17.7% | ↗ |
| Anderson Schock★★★★★★★★★★#6225 · hits 53% · avg +2.9% | B. Riley Securities | $20.00 → $30.00+50.0% | Buy | +230.8% | Reiterated | 17.06.26on TipRanks Jun 18 08:50 | +27.3%next day +4.7% · 5 days +7.5% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering ClearPoint Neuro
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $25.00 at a price of $12.21 (+104.8%); now: $25.00 at $9.07 (+175.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 1 | 1 |
| Buy | 2 | 4 | 4 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 28.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.32 (from $-0.36 to $-0.27). Last quarter: $-0.38.
Sales
Next quarter’s sales estimate — $12M (from $12M to $12M). Last quarter: $11M.
Best top-analyst consensus in the sector · Healthcare
About ClearPoint Neuro
- CEO: Joseph Michael Burnett
- Employees: 172
- 120 S. Sierra Avenue, Solana Beach, CA, 92075, US
- www.clearpointneuro.com
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Data from the stock’s TipRanks forecast page, read 201 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗